UroGen Pharma Ltd. — insider transactions
3 transactions on record · URGN · CIK 1668243
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$80.8K
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$80.8K
2026-10-08
Director share, 12m
0.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$80.8K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-09 | 2026-10-08 | 1 | Degnan Chris | Chief Financial Officer | Open market sale | 2,202 | $36.69 | $80.8K | filing |
| 2026-10-09 | 2026-10-08 | 1 | Degnan Chris | Chief Financial Officer | Exercise of derivative | 4,483 | — | — | filing |
| 2026-10-09 | 2026-10-08 | 1 | Degnan Chris | Chief Financial Officer | Exercise of derivative | 4,483 | $0.00 | — | filing |